Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v6-EN Version v1-EN
Language English English
Date Updated 2020-09-15 2020-06-10
Drug Identification Number 02462788 02462788
Brand name MAR-RIZATRIPTAN ODT MAR-RIZATRIPTAN ODT
Common or Proper name Rizatriptan ODT Rizatriptan ODT
Company Name MARCAN PHARMACEUTICALS INC MARCAN PHARMACEUTICALS INC
Ingredients RIZATRIPTAN RIZATRIPTAN
Strength(s) 5MG 5MG
Dosage form(s) TABLET (ORALLY DISINTEGRATING) TABLET (ORALLY DISINTEGRATING)
Route of administration ORAL ORAL ORAL ORAL
Packaging size 6 Tablets 6 Tablets
ATC code N02CC N02CC
ATC description ANTIMIGRAINE PREPARATIONS ANTIMIGRAINE PREPARATIONS
Reason for shortage Delay in shipping of the drug. Delay in shipping of the drug.
Anticipated start date 2020-06-10 2020-06-10
Actual start date 2020-06-10 2020-06-10
Estimated end date 2020-09-18 2020-08-30
Actual end date
Shortage status Actual shortage Anticipated shortage
Tier 3 Status No No
Company comments
Health Canada comments